4-碘-3-甲基苯酚 | 133921-27-4

• 物质功能分类: 有机原料 - 醇、酚、酚醇类化合物及衍生物 - 酚及其卤化、磺化、硝化或亚硝化衍生物
• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 4-碘-3-甲基苯酚
• 英文名称: 4-iodo-3-methylphenol
• CAS: 133921-27-4
• 化学式: C₇H₇IO
• mdl: MFCD09029708
• 分子量: 234.036
• InChiKey: IYKHMSCHNOEGSE-UHFFFAOYSA-N

物化性质

• 沸点：
  276.7±28.0 °C(Predicted)
• 密度：
  1.854±0.06 g/cm3(Predicted)
• 保留指数：
  1453

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2908199090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  应存放在室温、密封、干燥、避光的环境中。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-Iodo-3-methylphenol
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-Iodo-3-methylphenol
CAS number: 133921-27-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H7IO
Molecular weight: 234.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen Iodide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-碘-3-甲基苯酚 在 palladium diacetate 、 三苯基膦 potassium carbonate 、 异丙醇 作用下， 反应 14.0h， 以98%的产率得到间甲酚
  参考文献：
  名称：

  A practical palladium catalyzed dehalogenation of aryl halides and α-haloketones

  摘要：

  A practical and high-yielding protocol for the dehalogenation of aromatic halides is presented. In the presence of palladium acetate, triphenylphosphine, and potassium carbonate, a number of highly functionalized aromatic halides as well as alpha-haloketones were dehalogenated with alcohols as hydrogen donors. (C) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2007.03.061
• 作为产物：
  描述：

  间甲酚 在 potassium iodide 、 sodium hydroxide 、 potassium ferrate(VI) 作用下， 以 水 为溶剂， 反应 3.33h， 以86%的产率得到4-碘-3-甲基苯酚
  参考文献：
  名称：

  绿色高效的水中苯酚碘化方法

  摘要：

  在本文中，报道了酚的绿色转化为相应的碘化物衍生物。反应在水中进行，使用碘化钾作为碘源，高铁酸钾作为氧化剂。在温和且无毒的反应条件下，成功地以良好或优异的收率碘化了所选的酚。

  DOI：

  10.1080/15533174.2011.555856

文献信息

• [EN] TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE<br/>[FR] COMPOSÉS ALCÉNIQUES TÉTRASUBSTITUÉS ET LEUR UTILISATION
  申请人：EISAI R&D MAN CO LTD

  公开号：WO2016196342A1

  公开（公告）日：2016-12-08

  Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast cancer may be an ER-positive breast cancer and/or the subject in need of treatment may express a mutant ER-α protein.

  本文披露了化合物或其药用可接受盐，并使用这些化合物治疗乳腺癌的方法，通过向需要治疗的受试者施用这些化合物或其药用可接受盐的治疗有效量。乳腺癌可能是ER阳性乳腺癌，需要治疗的受试者可能表达突变的ER-α蛋白。
• Eco-friendly oxyiodination of aromatic compounds using ammonium iodide and hydrogen peroxide
  作者：N. Narender、K. Suresh Kumar Reddy、K.V.V. Krishna Mohan、S.J. Kulkarni

  DOI：10.1016/j.tetlet.2007.06.138

  日期：2007.8

  A new eco-friendly procedure for the oxyiodination of aromatic compounds with NH4I as an iodine source and H2O2 as an oxidant without any catalyst is presented.

  提出了一种新的环保方法，无需任何催化剂，即可使用NH 4 I作为碘源和H 2 O 2作为氧化剂对芳族化合物进行氧碘化。
• METHOD FOR PREPARING CRISABOROLE
  申请人：Jiangxi Synergy Pharmaceutical Co., Ltd

  公开号：US20210053995A1

  公开（公告）日：2021-02-25

  The invention relates to a method for preparing Crisaborole of Formula I, comprising using m-methylphenol as the starting material to obtain a target product through a five-step reaction. The starting materials and the raw materials used in each step of the method according to the present invention are cheap and easy to obtain, and the process is simple. The reaction of introducing boron atoms into the benzene ring to form an oxygen boron heterocycle is novel, with high yield and mild conditions, and is suitable for industrial production.

  该发明涉及一种制备化合物I的Crisaborole的方法，包括使用间甲酚作为起始物质，通过五步反应获得目标产物。根据本发明方法的每个步骤中使用的起始物质和原材料便宜且易获得，过程简单。将硼原子引入苯环形成氧硼杂环的反应是新颖的，产率高且条件温和，适合工业生产。
• Efficient and Practical Oxidative Bromination and Iodination of Arenes and Heteroarenes with DMSO and Hydrogen Halide: A Mild Protocol for Late-Stage Functionalization
  作者：Song Song、Xiang Sun、Xinwei Li、Yizhi Yuan、Ning Jiao

  DOI：10.1021/acs.orglett.5b00932

  日期：2015.6.19

  efficient and practical system for inexpensive bromination and iodination of arenes as well as heteroarenes by using readily available dimethyl sulfoxide (DMSO) and HX (X = Br, I) reagents is reported. This mild oxidative system demonstrates a versatile protocol for the synthesis of aryl halides. HX (X = Br, I) are employed as halogenating reagents when combined with DMSO which participates in the present

  据报道，通过使用容易获得的二甲基亚砜（DMSO）和HX（X = Br，I）试剂，可对芳烃和杂芳烃进行廉价的溴化和碘化的高效实用系统。这种温和的氧化系统显示了用于合成芳基卤化物的通用协议。当与DMSO结合使用时，HX（X = Br，I）被用作卤化试剂，DMSO作为一种温和且廉价的氧化剂参与了本发明的化学反应。该氧化系统适合于天然产物的后期溴化。公斤级实验（> 95％的收率）显示出工业应用的巨大潜力。
• [EN] ALKYNE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS<br/>[FR] COMPOSÉS DE TYPE ALCYNE EN TANT QU'INHIBITEURS DE LA S-NITROSOGLUTATHIONE RÉDUCTASE
  申请人：GLENMARK PHARMACEUTICALS SA

  公开号：WO2016055947A1

  公开（公告）日：2016-04-14

  Provided are compounds of formula (Ia) and pharmaceutically acceptable salts thereof, wherein A, B, R 1, R 2, m and n are as defined herein, which are active as inhibitors of S-Nitrosoglutathione reductase (GSNOR). These compounds prevent, inhibit, or suppress the action of GSNOR and are therefore useful in the treatment of GSNOR mediated diseases, disorders, syndromes or conditions such as, e.g., pulmonary hypertension, acute respiratory distress syndrome (ARDS), asthma, bronchospasm, cough, pneumonia, pulmonary fibrosis, interstitial lung diseases, cystic fibrosis and chronic obstructive pulmonary disease (COPD).

  提供的是式(Ia)的化合物及其药学上可接受的盐，其中A、B、R1、R2、m和n如本文所定义，这些化合物作为S-硝基谷胱甘肽还原酶(GSNOR)的抑制剂具有活性。这些化合物可以预防、抑制或抑制GSNOR的作用，因此在治疗GSNOR介导的疾病、疾病、综合征或病症方面具有用处，例如肺动脉高压、急性呼吸窘迫综合征(ARDS)、哮喘、支气管痉挛、咳嗽、肺炎、肺纤维化、间质性肺疾病、囊性纤维化和慢性阻塞性肺疾病(COPD)。